Sergio Fazio

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
   2020/01/08 by Jan Borén, M. John Chapman, M John Chapman +48 · 1 voice · 14 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Atherosclerosis and Cardiovascular Diseases #Cancer, Lipids, and Metabolism #Lipoproteins and Cardiovascular Health
2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
   2017/03/08 by Brian A. Ference, Henry N. Ginsberg, Ian Graham +23 · 1 voice · 1 citation
   Medicine · Immunology and Microbiology · #Diabetes, Cardiovascular Risks, and Lipoproteins #Lipoproteins and Cardiovascular Health #Atherosclerosis and Cardiovascular Diseases #Medicine #Consensus conference #Atherosclerotic cardiovascular disease #Statement (logic) #Disease #Internal medicine #Cardiology #Law
3. Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
   2024/09/01 by Doron Zahger, Gregory G. Schwartz, Weiming Du +23 · 1 citation
   Medicine · Biochemistry, Genetics and Molecular Biology · #Lipoproteins and Cardiovascular Health #Adipokines, Inflammation, and Metabolic Diseases #Protease and Inhibitor Mechanisms
4. Are statins diabetogenic?
   2011/04/15 by Uchechukwu K.A. Sampson, MacRae F. Linton, Sergio Fazio · 1 citation
   Medicine · #Lipoproteins and Cardiovascular Health #Diabetes, Cardiovascular Risks, and Lipoproteins #Diabetes Treatment and Management #Medicine #Rosuvastatin #Diabetes mellitus #Internal medicine #Statin #Rosuvastatin Calcium #Type 2 diabetes #Odds ratio #Endocrinology #Pharmacology